Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis Volume 8, 2007 - Issue 5
Journal homepage
312
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Riluzole metabolism and CYP1A1/2 polymorphisms in patients with ALS

Senda Ajroud‐Driss Davee Department of Neurology and Clinical NeurosciencesCorrespondence[email protected]
,
Mohammad Saeed Davee Department of Neurology and Clinical Neurosciences
,
Humaira Khan Davee Department of Neurology and Clinical Neurosciences
,
Nailah Siddique Davee Department of Neurology and Clinical Neurosciences
,
W. Y. Hung Davee Department of Neurology and Clinical Neurosciences
,
Robert Sufit Davee Department of Neurology and Clinical Neurosciences
,
Scott Heller Davee Department of Neurology and Clinical Neurosciences
,
Jennifer Armstrong Davee Department of Neurology and Clinical Neurosciences
,
Pat Casey Davee Department of Neurology and Clinical Neurosciences
,
Teepu Siddique Davee Department of Neurology and Clinical Neurosciences; Department of Cell and Molecular Biology; Northwestern University Institute of Neuroscience, Chicago, Illinois
&
Thomas J. Lukas Department of Molecular Pharmacology and Biological Chemistry, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
 show all
Pages 305-309 | Received 13 Apr 2007, Accepted 04 Jun 2007, Published online: 10 Jul 2009

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Shu-Feng Zhou, Bo Wang, Li-Ping Yang & Jun-Ping Liu. (2010) Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2. Drug Metabolism Reviews 42:2, pages 268-354.
Read now
Shu-Feng Zhou, Jun-Ping Liu & Balram Chowbay. (2009) Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metabolism Reviews 41:2, pages 89-295.
Read now

Articles from other publishers (10)

Rami A Al-Horani. (2023) Riluzole and its prodrugs for the treatment of Alzheimer’s disease. Pharmaceutical Patent Analyst 12:2, pages 79-85.
Crossref
Lucie BourguignonAnh Khoa VoBobo TongFred GeislerOrpheus MachDoris MaierJohn L.K. KramerLukas GrassnerCatherine R. Jutzeler. (2021) Natural Progression of Routine Laboratory Markers after Spinal Trauma: A Longitudinal, Multi-Cohort Study. Journal of Neurotrauma 38:15, pages 2151-2161.
Crossref
Scott E. Collibee, Gustave Bergnes, Alexander Muci, William F. BrowneIVIV, Marc Garard, Aaron C. Hinken, Alan J. Russell, Ion Suehiro, James Hartman, Raja Kawas, Pu-Ping Lu, Kenneth H. Lee, David Marquez, Matthew Tomlinson, Donghong Xu, Adam Kennedy, Darren Hwee, Julia Schaletzky, Kwan Leung, Fady I. Malik, David J. MorgansJr.Jr. & Bradley P. Morgan. (2018) Discovery of Tirasemtiv , the First Direct Fast Skeletal Muscle Troponin Activator . ACS Medicinal Chemistry Letters 9:4, pages 354-358.
Crossref
Paul Grant, Cristan Farmer, Jane Song, Timothy Kish & Susan Swedo. (2017) Riluzole Serum Concentration in Pediatric Patients Treated for Obsessive-Compulsive Disorder. Journal of Clinical Psychopharmacology 37:6, pages 713-716.
Crossref
J.-C. Corvol, D. Devos, J.-S. Hulot & L. Lacomblez. (2015) Clinical implications of neuropharmacogenetics. Revue Neurologique 171:6-7, pages 482-497.
Crossref
Amber Cardoos, Aya Inamori, Gerard Sanacora, Maurizio Fava & David Mischoulon. (2013) Delayed Amnesic Syndrome after Riluzole Use in Major Depressive Disorder: A Case Report. Psychosomatics 54:5, pages 488-492.
Crossref
Omar Sierra Bello, Janneth Gonzalez, Francisco Capani & George E. Barreto. (2012) In silico docking reveals possible Riluzole binding sites on Nav1.6 sodium channel: Implications for amyotrophic lateral sclerosis therapy. Journal of Theoretical Biology 315, pages 53-63.
Crossref
Mark C. Bellingham. (2011) A Review of the Neural Mechanisms of Action and Clinical Efficiency of Riluzole in Treating Amyotrophic Lateral Sclerosis: What have we Learned in the Last Decade?. CNS Neuroscience & Therapeutics 17:1, pages 4-31.
Crossref
Paul GrantJane Y. SongSusan E. Swedo. (2010) Review of the Use of the Glutamate Antagonist Riluzole in Psychiatric Disorders and a Description of Recent Use in Childhood Obsessive-Compulsive Disorder. Journal of Child and Adolescent Psychopharmacology 20:4, pages 309-315.
Crossref
Benjamin Rix Brooks. (2009) Managing amyotrophic lateral sclerosis: Slowing disease progression and improving patient quality of life. Annals of Neurology 65:S1, pages S17-S23.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.